Vai al contenuto
ApertoContributoMedical equipment and pharma

Development of cell-free protein synthesis platforms for discovery and/or production of biologicals[E8]

UnknownEuropean Commission[E1]

In parole semplici

Cosa finanzia
Call: Cluster 1 - Health (Single stage - 2027/1). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”.
Chi può partecipare
  • EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.
  • Aperto a: Universities and research
  • Fase: Prototype and MVP
Date
Apre il 29 ott 2026.Chiude:
Scadenza dell'ente finanziatore: 17 feb 2027, 01:00 Ora dell’Europa centrale (UTC+1). UTC: 17 feb 2027, 00:00 UTC.
Finanziamento
EUR 11.000.000 in totaleTipo di aiuto: Grant.
Ente finanziatore
European CommissionVedi cos'altro offre questo ente.
Bando e domanda

Il bando, le regole e il modulo di domanda sono sulla pagina dell'ente. Leggili prima di fare domanda.

Apre[E6]
29 ott 2026
Chiude[E2]
17 feb 2027, 01:00 Ora dell’Europa centrale (UTC+1)
Finanziamento totale[E9]
EUR 11.000.000
Per richiedente
Non indicato
Ultimo controllo
4 ore fa

Sul finanziamento

Dal bando

Call: Cluster 1 - Health (Single stage - 2027/1). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Biopharmaceutical industries get access to streamlined development and production processes for peptide- or protein-based biologicals. Health systems benefit from the availability of enhanced or decentralised production systems for innovative health technologies that involve peptides or proteins, and which improve health and care. Citizens and patients will benefit from better access, availability and affordability of pharmaceuticals based on biologicals. Scope: Cell-Free Protein Synthesis (CFPS) has been employed in fundamental biological research for decades, however, interest for the approach as a viable means for drug development and production has only emerged in recent years. The advantages that CFPS provides in terms of efficiency, simplicity, flexibility, cost- and time savings outweigh the hurdles that are still to be overcome for CFPS to become a routine manufacturing system for peptide- or protein-based biologicals. Currently, there are several CFPS systems used that are either based on prokaryotic or eukaryotic cell lysates (including mammalian) or fully synthetic systems consi…[E3]

Chi può partecipare

I dettagli del bando sono mostrati come li ha pubblicati la fonte. I fatti e i requisiti che estraiamo sono scritti in inglese.

  • Aperto aUniversities and research. Etichettato da SLETOR in base alle parole del bando.
  • CondizioneEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

Rischi e incognite

  • RischioThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
  • SconosciutoWe read the funder's listing, not the full guidance or application forms.

Aggiornamenti

  1. Aperto alle offerte · 29 ott 2026, 07:41 UTC

    The funder published the call with a future closing date.

    Modificato: status, notice type, published at (record di origine Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01))

  2. Visto per la prima volta · 28 ott 2026, 21:22 UTC

    The funder announced the call. Applications have not opened yet.

    Record di origine: Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01)

Evidenze

9 dati

Ogni dato di questa pagina viene dal bando dell'ente. Ogni voce mostra il record e il campo da cui è stato letto.

  1. E1

    The funder is European Commission.

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/type/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  2. E2

    Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

    “2027-02-17T00:00:00.000+0000”

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/deadlineDate/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  3. E3

    The buyer describes the requirement in the notice.

    “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deli…”

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/descriptionByte/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  4. E4

    EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

    “EU call topic”

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/type/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  5. E5

    This is an EU call for proposals.

    “31094502”

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/status/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  6. E6

    Applications open on 29 Oct 2026.

    “2026-10-29T00:00:00.000+0000”

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/startDate/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  7. E7

    The Funding & Tenders Portal gives the status as open for submission.

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/status/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  8. E8

    The notice is titled "Development of cell-free protein synthesis platforms for discovery and/or production of biologicals".

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/title/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

  9. E9

    The EU contribution per grant is up to EUR 11,000,000 (from EUR 3,000,000).

    Da Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), campo /metadata/budgetOverview/0, letto 29 ott 2026, 07:41 UTC · fonte (si apre in una nuova scheda)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licenza dei dati: Creative Commons Attribution 4.0 (European Commission) (si apre in una nuova scheda). I recapiti personali presenti nei bandi non vengono conservati né mostrati.